Fred Telling - Jun 23, 2022 Form 4/A - Amendment Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Stock symbol: OGEN
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 6/27/2022, 04:10 PM
Date Of Original Report: Jun 24, 2022
Previous filing: Jun 21, 2022
Next filing: Aug 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Non-Employee Director Option (Right to Buy)	Award	$0	+250K		$0.00	250K	Jun 23, 2022	Common Stock	250K	$0.30	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022.
F2	Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4.